News & Blog

New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology

A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]

NBTS Brain Tumor Clinical Trials Report: Q3 2020

It can be hard for patients and care partners to keep track of new clinical trial opportunities opening across the country, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many brain tumor clinical trials still actively enrolling patients, and this report provides a summary of the studies that […]

Share